指南与共识自身免疫性与大疱性皮肤病

天疱疮的诊断与管理:国际专家小组的建议

Diagnosis and management of pemphigus: Recommendations of an international panel of experts.
指南 / 共识 · J Am Acad Dermatol · 2018-02-10

本共识基于欧洲皮肤病论坛与欧洲皮肤病与性病学会指南设计初步调查,经2016年3月美国皮肤病学会年会期间的国际大疱性疾病共识组讨论后开展第二轮德尔菲调查,39名专家参与第一轮、来自21个国家的54名专家完成第二轮,条目由175项精简为24项,最终建议将静脉CD20抑制剂作为中重度天疱疮的一线治疗选择。

要点

  • 39名专家参与第一轮德尔菲调查,21个国家的54名专家完成第二轮。
  • 调查条目由第一轮的175项精简为第二轮的24项。
  • 共识将静脉CD20抑制剂列为中重度天疱疮的一线治疗选择。

核心结论

  • 该国际共识建议将静脉CD20抑制剂作为中重度天疱疮的一线治疗选择。

研究设计与样本

  • 由国际专家小组开展的德尔菲共识流程,初步调查基于欧洲皮肤病论坛与欧洲皮肤病与性病学会指南,结果在2016年3月美国皮肤病学会年会期间的国际大疱性疾病共识组会议上讨论。

主要发现

  • 39名专家参与第一轮德尔菲调查,来自21个国家的54名专家完成第二轮调查。
  • 调查条目由第一轮的175项精简为第二轮的24项。

关键数值与推荐

  • 共识将静脉CD20抑制剂列为中重度天疱疮的一线治疗选择。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 每条建议代表多数意见,因此可能未反映所有可用的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several European countries recently developed international diagnostic and management guidelines for pemphigus, which have been instrumental in the standardization of pemphigus management. OBJECTIVE: We now present results from a subsequent Delphi consensus to broaden the generalizability of the recommendations. METHODS: A preliminary survey, based on the European Dermatology Forum and the European Academy of Dermatology and Venereology guidelines, was sent to a panel of international experts to determine the level of consensus. The results were discussed at the International Bullous Diseases Consensus Group in March 2016 during the annual American Academy of Dermatology conference. Following the meeting, a second survey was sent to more experts to achieve greater international consensus. RESULTS: The 39 experts participated in the first round of the Delphi survey, and 54 experts from 21 countries completed the second round. The number of statements in the survey was reduced from 175 topics in Delphi I to 24 topics in Delphi II on the basis of Delphi results and meeting discussion. LIMITATIONS: Each recommendation represents the majority opinion and therefore may not reflect all possible treatment options available. CONCLUSIONS: We present here the recommendations resulting from this Delphi process. This international consensus includes intravenous CD20 inhibitors as a first-line therapy option for moderate-to-severe pemphigus.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Murrell DF, Peña S, Joly P, et al. Diagnosis and management of pemphigus: Recommendations of an international panel of experts. J Am Acad Dermatol. 2018. PMID: 29438767. doi:10.1016/j.jaad.2018.02.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。